MediWound Ltd. (MDWD) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mediwound Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.212 Good day, and welcome to MediWoon's second quarter 2023 earnings call. 00:00:05.212 -- 00:00:09.735 Today's conference is being recorded. At this time, I would like to turn the conference 00:00:09.735 -- 00:00:13.357 over to Monique Cossie of Lifesize Advisors. 00:00:13.357 -- 00:00:15.737 Please go ahead. 00:00:17.039 -- 00:00:20.361 Thank you, Operator, and welcome, everyone. 00:00:20.361 -- 00:00:25.384 Yesterday, after the market closed, MediWoon issued a press release announcing financial 00:00:25.384 -- 00:00:29.435 results for the second quarter ended June 30, 2023. 00:00:30.287 -- 00:00:35.732 You may access that release on the company's website under the Investors tab. 00:00:35.732 -- 00:00:40.936 With us today are Ofra Gonen, Chief Executive Officer of Mediwound, Hani 00:00:40.936 -- 00:00:46.320 Luxemburg, Chief Financial Officer, and Barry Wolfenson, Executive Vice President 00:00:46.320 -- 00:00:49.662 of Strategy and Corporate Development. 00:00:49.703 -- 00:00:54.047 Following our prepared remarks, we will open the call for Q&A. 00:00:54.047 -- 00:00:59.164 Before we begin, I would like to remind everyone that statements made during this call 00:00:59.164 -- 00:01:04.225 including the Q&A session relating to MediWomb's expected future performance, 00:01:04.225 -- 00:01:09.626 future business prospects, or future events or plans, are forward-looking statements 00:01:09.626 -- 00:01:15.177 as defined under the Private Securities Litigation Reform Act of 1995. 00:01:15.707 -- 00:01:20.248 Although the company believes that the expectations reflected in such forward-looking 00:01:20.248 -- 00:01:24.049 statements are based upon reasonable assumptions, 00:01:24.049 -- 00:01:29.076 actual outcomes and results are subject t...